Annual SG&A
$9.20 M
-$1.59 M-14.75%
31 December 2023
Summary:
Windtree Therapeutics annual selling, general & administrative expenses is currently $9.20 million, with the most recent change of -$1.59 million (-14.75%) on 31 December 2023. During the last 3 years, it has fallen by -$5.75 million (-38.45%). WINT annual SG&A is now -50.29% below its all-time high of $18.50 million, reached on 31 December 2005.WINT Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.77 M
+$1.18 M+74.51%
30 September 2024
Summary:
Windtree Therapeutics quarterly selling, general & administrative expenses is currently $2.77 million, with the most recent change of +$1.18 million (+74.51%) on 30 September 2024. Over the past year, it has increased by +$193.00 thousand (+7.48%). WINT quarterly SG&A is now -68.06% below its all-time high of $8.68 million, reached on 31 March 2006.WINT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$3.37 B
-$9.14 M-0.27%
30 September 2024
Summary:
Windtree Therapeutics TTM selling, general & administrative expenses is currently -$3.37 billion, with the most recent change of -$9.14 million (-0.27%) on 30 September 2024. Over the past year, it has dropped by -$3.38 billion (-35498.16%). WINT TTM SG&A is now -76601.39% below its all-time high of $22.92 million, reached on 31 March 2006.WINT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WINT Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.8% | +7.5% | -10000.0% |
| 3 y3 years | -38.5% | -20.0% | -10000.0% |
| 5 y5 years | +23.9% | -18.3% | -10000.0% |
WINT Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -38.5% | at low | -20.0% | +74.5% | -13.2% | at low |
| 5 y | 5 years | -38.5% | +23.9% | -42.5% | +74.5% | -26.4% | at low |
| alltime | all time | -50.3% | +607.5% | -68.1% | +793.3% | <-9999.0% | at low |
Windtree Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.77 M(+74.5%) | $8.42 M(+2.3%) |
| June 2024 | - | $1.59 M(-26.2%) | $8.23 M(-9.2%) |
| Mar 2024 | - | $2.15 M(+12.9%) | $9.06 M(-1.5%) |
| Dec 2023 | $9.20 M(-14.8%) | $1.91 M(-26.1%) | $9.20 M(-3.5%) |
| Sept 2023 | - | $2.58 M(+6.6%) | $9.53 M(-0.8%) |
| June 2023 | - | $2.42 M(+5.6%) | $9.61 M(-4.8%) |
| Mar 2023 | - | $2.29 M(+2.2%) | $10.09 M(-6.5%) |
| Dec 2022 | $10.79 M(-25.4%) | $2.24 M(-15.5%) | $10.79 M(-6.3%) |
| Sept 2022 | - | $2.65 M(-8.7%) | $11.51 M(-6.6%) |
| June 2022 | - | $2.91 M(-2.7%) | $12.33 M(-3.6%) |
| Mar 2022 | - | $2.99 M(+0.7%) | $12.79 M(-11.6%) |
| Dec 2021 | $14.47 M(-3.2%) | $2.97 M(-14.5%) | $14.47 M(-3.1%) |
| Sept 2021 | - | $3.47 M(+2.8%) | $14.93 M(-8.3%) |
| June 2021 | - | $3.37 M(-27.8%) | $16.29 M(-0.5%) |
| Mar 2021 | - | $4.67 M(+36.3%) | $16.37 M(+9.5%) |
| Dec 2020 | $14.94 M(+20.5%) | $3.43 M(-29.0%) | $14.94 M(+7.3%) |
| Sept 2020 | - | $4.82 M(+39.7%) | $13.93 M(+11.4%) |
| June 2020 | - | $3.45 M(+6.5%) | $12.50 M(+1.7%) |
| Mar 2020 | - | $3.24 M(+34.3%) | $12.29 M(-0.9%) |
| Dec 2019 | $12.40 M(+67.1%) | $2.41 M(-28.9%) | $12.40 M(-2.9%) |
| Sept 2019 | - | $3.40 M(+4.8%) | $12.78 M(+17.4%) |
| June 2019 | - | $3.24 M(-3.4%) | $10.88 M(+23.0%) |
| Mar 2019 | - | $3.35 M(+20.4%) | $8.85 M(+19.3%) |
| Dec 2018 | $7.42 M(+11.5%) | $2.79 M(+85.8%) | $7.42 M(+27.6%) |
| Sept 2018 | - | $1.50 M(+24.2%) | $5.82 M(-4.1%) |
| June 2018 | - | $1.21 M(-37.3%) | $6.07 M(-8.9%) |
| Mar 2018 | - | $1.93 M(+62.9%) | $6.66 M(+0.1%) |
| Dec 2017 | $6.66 M(-20.5%) | $1.18 M(-32.4%) | $6.66 M(-2.0%) |
| Sept 2017 | - | $1.75 M(-3.0%) | $6.79 M(+2.0%) |
| June 2017 | - | $1.80 M(-6.1%) | $6.66 M(+0.3%) |
| Mar 2017 | - | $1.92 M(+45.6%) | $6.64 M(-20.7%) |
| Dec 2016 | $8.37 M(-23.9%) | $1.32 M(-18.2%) | $8.37 M(-9.6%) |
| Sept 2016 | - | $1.61 M(-9.5%) | $9.26 M(-4.6%) |
| June 2016 | - | $1.78 M(-51.2%) | $9.71 M(-14.1%) |
| Mar 2016 | - | $3.66 M(+65.4%) | $11.31 M(+2.8%) |
| Dec 2015 | $11.00 M(-34.2%) | $2.21 M(+7.5%) | $11.00 M(-12.2%) |
| Sept 2015 | - | $2.06 M(-39.2%) | $12.53 M(-14.2%) |
| June 2015 | - | $3.38 M(+0.9%) | $14.60 M(-6.8%) |
| Mar 2015 | - | $3.35 M(-10.3%) | $15.66 M(-6.4%) |
| Dec 2014 | $16.73 M(+0.1%) | $3.74 M(-9.4%) | $16.73 M(-2.0%) |
| Sept 2014 | - | $4.13 M(-7.2%) | $17.07 M(-1.0%) |
| June 2014 | - | $4.45 M(+0.5%) | $17.24 M(+1.9%) |
| Mar 2014 | - | $4.42 M(+8.7%) | $16.92 M(+1.2%) |
| Dec 2013 | $16.72 M(+1.7%) | $4.07 M(-5.3%) | $16.72 M(-12.8%) |
| Sept 2013 | - | $4.30 M(+4.1%) | $19.18 M(+0.2%) |
| June 2013 | - | $4.13 M(-2.2%) | $19.14 M(+2.8%) |
| Mar 2013 | - | $4.22 M(-35.4%) | $18.62 M(+13.2%) |
| Dec 2012 | $16.44 M(+109.1%) | $6.53 M(+53.5%) | $16.44 M(+39.3%) |
| Sept 2012 | - | $4.25 M(+17.9%) | $11.80 M(+21.2%) |
| June 2012 | - | $3.61 M(+76.4%) | $9.73 M(+20.3%) |
| Mar 2012 | - | $2.05 M(+8.4%) | $8.09 M(+2.9%) |
| Dec 2011 | $7.86 M(-6.3%) | $1.89 M(-13.7%) | $7.86 M(-2.8%) |
| Sept 2011 | - | $2.19 M(+11.3%) | $8.09 M(+9.7%) |
| June 2011 | - | $1.97 M(+8.0%) | $7.38 M(+1.4%) |
| Mar 2011 | - | $1.82 M(-14.1%) | $7.28 M(-13.3%) |
| Dec 2010 | $8.39 M(-17.1%) | $2.12 M(+43.6%) | $8.39 M(+1.3%) |
| Sept 2010 | - | $1.48 M(-20.9%) | $8.29 M(-10.2%) |
| June 2010 | - | $1.86 M(-36.4%) | $9.23 M(-7.3%) |
| Mar 2010 | - | $2.93 M(+45.5%) | $9.96 M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $10.12 M(-38.4%) | $2.02 M(-16.6%) | $10.12 M(-9.9%) |
| Sept 2009 | - | $2.42 M(-6.8%) | $11.23 M(-10.4%) |
| June 2009 | - | $2.59 M(-16.3%) | $12.54 M(-16.5%) |
| Mar 2009 | - | $3.10 M(-0.8%) | $15.02 M(-8.6%) |
| Dec 2008 | $16.43 M(+19.5%) | $3.12 M(-16.2%) | $16.43 M(-7.1%) |
| Sept 2008 | - | $3.73 M(-26.6%) | $17.69 M(+3.4%) |
| June 2008 | - | $5.08 M(+12.7%) | $17.11 M(+10.4%) |
| Mar 2008 | - | $4.50 M(+2.8%) | $15.50 M(+12.7%) |
| Dec 2007 | $13.75 M(-25.2%) | $4.38 M(+39.2%) | $13.75 M(+11.6%) |
| Sept 2007 | - | $3.15 M(-9.2%) | $12.32 M(+3.6%) |
| June 2007 | - | $3.46 M(+25.8%) | $11.90 M(-4.5%) |
| Mar 2007 | - | $2.75 M(-6.9%) | $12.46 M(-32.2%) |
| Dec 2006 | $18.39 M(-0.6%) | $2.96 M(+8.6%) | $18.39 M(-11.4%) |
| Sept 2006 | - | $2.72 M(-32.3%) | $20.75 M(-9.2%) |
| June 2006 | - | $4.02 M(-53.7%) | $22.85 M(-0.3%) |
| Mar 2006 | - | $8.68 M(+63.1%) | $22.92 M(+23.8%) |
| Dec 2005 | $18.50 M(+38.9%) | $5.32 M(+10.5%) | $18.50 M(+2.0%) |
| Sept 2005 | - | $4.82 M(+17.6%) | $18.14 M(+11.8%) |
| June 2005 | - | $4.09 M(-4.1%) | $16.23 M(+6.0%) |
| Mar 2005 | - | $4.27 M(-13.9%) | $15.31 M(+14.9%) |
| Dec 2004 | $13.32 M(+132.8%) | $4.96 M(+70.5%) | $13.32 M(+28.0%) |
| Sept 2004 | - | $2.91 M(-8.4%) | $10.41 M(+17.3%) |
| June 2004 | - | $3.17 M(+39.2%) | $8.87 M(+29.8%) |
| Mar 2004 | - | $2.28 M(+11.6%) | $6.84 M(+19.5%) |
| Dec 2003 | $5.72 M(+4.8%) | $2.04 M(+48.6%) | $5.72 M(+18.4%) |
| Sept 2003 | - | $1.38 M(+20.9%) | $4.83 M(-5.1%) |
| June 2003 | - | $1.14 M(-2.6%) | $5.09 M(-7.3%) |
| Mar 2003 | - | $1.17 M(+1.0%) | $5.49 M(+0.6%) |
| Dec 2002 | $5.46 M(+7.7%) | $1.16 M(-29.3%) | $5.46 M(-10.0%) |
| Sept 2002 | - | $1.63 M(+6.2%) | $6.06 M(+12.7%) |
| June 2002 | - | $1.54 M(+35.9%) | $5.38 M(+11.5%) |
| Mar 2002 | - | $1.13 M(-35.7%) | $4.83 M(+1.6%) |
| Dec 2001 | $5.07 M(-4.1%) | $1.76 M(+85.8%) | $4.75 M(-26.7%) |
| Sept 2001 | - | $948.00 K(-3.7%) | $6.48 M(+8.6%) |
| June 2001 | - | $984.00 K(-6.7%) | $5.97 M(-4.3%) |
| Mar 2001 | - | $1.05 M(-69.8%) | $6.24 M(+5.4%) |
| Dec 2000 | $5.28 M(+118.2%) | $3.49 M(+700.9%) | $5.92 M(+88.1%) |
| Sept 2000 | - | $436.00 K(-65.2%) | $3.15 M(+1.2%) |
| June 2000 | - | $1.25 M(+70.6%) | $3.11 M(+21.7%) |
| Mar 2000 | - | $735.00 K(+1.9%) | $2.56 M(+5.6%) |
| Dec 1999 | $2.42 M(-13.5%) | $721.00 K(+80.3%) | $2.42 M(-6.9%) |
| Sept 1999 | - | $400.00 K(-42.9%) | $2.60 M(-3.7%) |
| June 1999 | - | $700.00 K(+16.7%) | $2.70 M(-3.6%) |
| Mar 1999 | - | $600.00 K(-33.3%) | $2.80 M(0.0%) |
| Dec 1998 | $2.80 M(+55.6%) | $900.00 K(+80.0%) | $2.80 M(-6.7%) |
| Sept 1998 | - | $500.00 K(-37.5%) | $3.00 M(+11.1%) |
| June 1998 | - | $800.00 K(+33.3%) | $2.70 M(-3.6%) |
| Mar 1998 | - | $600.00 K(-45.5%) | $2.80 M(+12.0%) |
| Dec 1997 | $1.80 M(+38.5%) | $1.10 M(+450.0%) | $2.50 M(+150.0%) |
| Sept 1997 | - | $200.00 K(-77.8%) | $1.00 M(-37.5%) |
| June 1997 | - | $900.00 K(+200.0%) | $1.60 M(+77.8%) |
| Mar 1997 | - | $300.00 K(-175.0%) | $900.00 K(-18.2%) |
| Dec 1996 | $1.30 M(-48.0%) | -$400.00 K(-150.0%) | $1.10 M(-26.7%) |
| Sept 1996 | - | $800.00 K(+300.0%) | $1.50 M(+114.3%) |
| June 1996 | - | $200.00 K(-60.0%) | $700.00 K(-30.0%) |
| Mar 1996 | - | $500.00 K(0.0%) | $1.00 M(+66.7%) |
| Dec 1995 | $2.50 M | - | - |
| June 1995 | - | $500.00 K(+400.0%) | $600.00 K(+500.0%) |
| Mar 1995 | - | $100.00 K | $100.00 K |
FAQ
- What is Windtree Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Windtree Therapeutics?
- What is Windtree Therapeutics annual SG&A year-on-year change?
- What is Windtree Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly SG&A year-on-year change?
- What is Windtree Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Windtree Therapeutics?
- What is Windtree Therapeutics TTM SG&A year-on-year change?
What is Windtree Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of WINT is $9.20 M
What is the all time high annual SG&A for Windtree Therapeutics?
Windtree Therapeutics all-time high annual selling, general & administrative expenses is $18.50 M
What is Windtree Therapeutics annual SG&A year-on-year change?
Over the past year, WINT annual selling, general & administrative expenses has changed by -$1.59 M (-14.75%)
What is Windtree Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of WINT is $2.77 M
What is the all time high quarterly SG&A for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly selling, general & administrative expenses is $8.68 M
What is Windtree Therapeutics quarterly SG&A year-on-year change?
Over the past year, WINT quarterly selling, general & administrative expenses has changed by +$193.00 K (+7.48%)
What is Windtree Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of WINT is -$3.37 B
What is the all time high TTM SG&A for Windtree Therapeutics?
Windtree Therapeutics all-time high TTM selling, general & administrative expenses is $22.92 M
What is Windtree Therapeutics TTM SG&A year-on-year change?
Over the past year, WINT TTM selling, general & administrative expenses has changed by -$3.38 B (-35498.16%)